Minohara, K., Matoba, T., Kawakita, D., Takano, G., Oguri, K., Murashima, A., . . . Iwasaki, S. (2021). Novel Prognostic Score for recurrent or metastatic head and neck cancer patients treated with Nivolumab. Nature Portfolio.
Style de citation Chicago (17e éd.)Minohara, Kiyoshi, et al. Novel Prognostic Score for Recurrent or Metastatic Head and Neck Cancer Patients Treated with Nivolumab. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Minohara, Kiyoshi, et al. Novel Prognostic Score for Recurrent or Metastatic Head and Neck Cancer Patients Treated with Nivolumab. Nature Portfolio, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.